2011 Board Compensation in the Life Sciences Industry Report is immediately available- click here to learn more!
2011 Executive Pay in the Biopharmaceutical Industry Report is immediately available - click here to learn more!
2011 Executive Pay in the Medical Device Industry Report is immediately available- click here to learn more!
Top 5 provides compensation consulting and research services
Our 2011 Executive Pay Reports for the Medical Device and Biopharmaceutical industries are instantly available via email.
Produced annually since 1994, our reports covering the two main sectors in the life sciences industry are widely considered to be the 'gold standard' of objective and authoritative data. For 2011, we have enhanced the reports by adding marcap to the set of company parameters used to break out pay levels. The 2011 reports present three sets of analysis that define total direct compensation (base + bonus + annual equity grant value) by six levels of
With all three sets of reports, any size company, in any stage of development can find vital market comparison data for key executive positions. These reports will keep you abreast of important compensation trends affecting your industry.
Our 2011 Board Compensation in the Life Sciences Industry report offers the same depth and ease of use as our highly regarded executive pay reports, and draws from our analysis of recent filings by publicly traded U.S. companies.
The study has data from 217 publicly-traded medical device and 332 biopharmaceutical companies. The data is broken out by industry sector (device and biopharma) and by market capitalization, ensuring that relevant data is available for all device or biopharm companies, regardless of product mix, size or stage-of-development.
The report is available in Acrobat format, with a complete set of tables and graphs. An optional Excel data set is available if you want to conduct your own analysis of the data. The Excel data set covers all companies referenced in the Acrobat report, with device and biopharm companies listed separately for ease of analysis.
Top 5 conducted its annual "Flash" survey covering salary increase budgets in life sciences companies. The survey had 98 participants, including Medtronic, Sanofi-Aventis, Edwards Lifesciences, CooperVision, St. Jude Medical, STERIS, Nipro Diagnostics, NxStage Medical, Laboratory Corp of America, Greatbatch, UCB, and Gen-Probe.
Here is a summary of what the survey covered:
Data is broken out by sector (medical device/biopharm), public vs. private companies, and by U.S. employment size.
If you would like to receive a complimentary copy of the full report, please complete our online Request for Information form.
